These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 31511226

  • 1. Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy.
    Chen P, Yu G, Zhang X, Xie X, Wang J, Shi S, Liu L, Lv J, Zhang H.
    Clin J Am Soc Nephrol; 2019 Oct 07; 14(10):1458-1465. PubMed ID: 31511226
    [Abstract] [Full Text] [Related]

  • 2. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression.
    Zhao N, Hou P, Lv J, Moldoveanu Z, Li Y, Kiryluk K, Gharavi AG, Novak J, Zhang H.
    Kidney Int; 2012 Oct 07; 82(7):790-6. PubMed ID: 22673888
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma D-dimer as a potential predictor of progression in IgA nephropathy: a cohort study.
    Yu G, Jiang Y, Xu Z, Cheng J, Li H, Li X, Chen J.
    Ren Fail; 2023 Oct 07; 45(2):2251587. PubMed ID: 37724549
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L, Fernández-Fresnedo G, Benito-Hernández A, Mazón J, de Cos M, Oviedo MV, San Segundo D, López-Hoyos M, Gómez-Román J, Ruiz JC, Rodrigo E.
    Nefrologia (Engl Ed); 2021 Oct 07; 41(3):311-320. PubMed ID: 36166247
    [Abstract] [Full Text] [Related]

  • 7. Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathy.
    Wang M, Lv J, Chen P, Yu G, Shi S, Liu L, Zhou X, Xu D, Zhao M, Zhang H.
    Nephrol Dial Transplant; 2021 Jan 25; 36(2):288-294. PubMed ID: 31603230
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
    Elíasdóttir S, Khramova A, Saeed A, Guron G, Boi R, Mölne J, Ebefors K, Nyström J.
    BMC Nephrol; 2023 Jun 07; 24(1):160. PubMed ID: 37286948
    [Abstract] [Full Text] [Related]

  • 9. Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients.
    Chiu YL, Lin WC, Shu KH, Fang YW, Chang FC, Chou YH, Wu CF, Chiang WC, Lin SL, Chen YM, Wu MS.
    Front Immunol; 2021 Jun 07; 12():638309. PubMed ID: 34177889
    [Abstract] [Full Text] [Related]

  • 10. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
    Maixnerova D, Ling C, Hall S, Reily C, Brown R, Neprasova M, Suchanek M, Honsova E, Zima T, Novak J, Tesar V.
    PLoS One; 2019 Jun 07; 14(2):e0212254. PubMed ID: 30794576
    [Abstract] [Full Text] [Related]

  • 11. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
    Camilla R, Suzuki H, Daprà V, Loiacono E, Peruzzi L, Amore A, Ghiggeri GM, Mazzucco G, Scolari F, Gharavi AG, Appel GB, Troyanov S, Novak J, Julian BA, Coppo R.
    Clin J Am Soc Nephrol; 2011 Aug 07; 6(8):1903-11. PubMed ID: 21784819
    [Abstract] [Full Text] [Related]

  • 12. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
    Zhang J, Wang C, Tang Y, Peng H, Ye ZC, Li CC, Lou TQ.
    Nephrology (Carlton); 2013 Feb 07; 18(2):125-31. PubMed ID: 23134230
    [Abstract] [Full Text] [Related]

  • 13. A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.
    Lafayette RA, Canetta PA, Rovin BH, Appel GB, Novak J, Nath KA, Sethi S, Tumlin JA, Mehta K, Hogan M, Erickson S, Julian BA, Leung N, Enders FT, Brown R, Knoppova B, Hall S, Fervenza FC.
    J Am Soc Nephrol; 2017 Apr 07; 28(4):1306-1313. PubMed ID: 27821627
    [Abstract] [Full Text] [Related]

  • 14. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
    Placzek WJ, Yanagawa H, Makita Y, Renfrow MB, Julian BA, Rizk DV, Suzuki Y, Novak J, Suzuki H.
    PLoS One; 2018 Apr 07; 13(1):e0190967. PubMed ID: 29324897
    [Abstract] [Full Text] [Related]

  • 15. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.
    Kidney Int; 2018 Mar 07; 93(3):700-705. PubMed ID: 29329643
    [Abstract] [Full Text] [Related]

  • 16. Interaction between GALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy.
    Wang YN, Zhou XJ, Chen P, Yu GZ, Zhang X, Hou P, Liu LJ, Shi SF, Lv JC, Zhang H.
    J Am Soc Nephrol; 2021 Mar 07; 32(3):545-552. PubMed ID: 33593824
    [Abstract] [Full Text] [Related]

  • 17. Porphyromonas gingivalis infection in the oral cavity is associated with elevated galactose-deficient IgA1 and increased nephritis severity in IgA nephropathy.
    Ito S, Misaki T, Nagasawa Y, Nomura R, Naka S, Fukunaga A, Matsuoka D, Matayoshi S, Matsumoto-Nakano M, Nakano K.
    Clin Exp Nephrol; 2024 Mar 07; 28(3):192-200. PubMed ID: 37806974
    [Abstract] [Full Text] [Related]

  • 18. The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.
    Schmitt R, Ståhl AL, Olin AI, Kristoffersson AC, Rebetz J, Novak J, Lindahl G, Karpman D.
    J Immunol; 2014 Jul 01; 193(1):317-26. PubMed ID: 24850720
    [Abstract] [Full Text] [Related]

  • 19. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
    Berthoux F, Suzuki H, Thibaudin L, Yanagawa H, Maillard N, Mariat C, Tomino Y, Julian BA, Novak J.
    J Am Soc Nephrol; 2012 Sep 01; 23(9):1579-87. PubMed ID: 22904352
    [Abstract] [Full Text] [Related]

  • 20. Oxidative stress and macrophage infiltration in IgA nephropathy.
    Caliskan Y, Demir E, Karatay E, Ozluk Y, Mirioglu S, Dirim AB, Artan AS, Usta Akgul S, Oto OA, Savran Oguz F, Turkmen A, Lentine KL, Yazici H.
    J Nephrol; 2022 May 01; 35(4):1101-1111. PubMed ID: 34787798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.